The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.
We're encouraged that Gilead Sciences is taking meaningful action to bring prices down for cash-paying customers.
The mobile app offers a more personalized experience for members, providing on-the-go access to benefit information.
Since 2008, brand medications have risen in price an average 232%. We need to work with pharma and the government for common-sense legislation and regulatory changes.
Expanded discounts, pharmacogenomic testing and innovative patient engagement tools offered by three SafeGuardRx® programs.
The market for purchasing drugs can be complex, but with MAC pricing, multi-sourced generic medications are kept as affordable as possible in the U.S.
Working with Regeneron and Sanofi, Express Scripts directly delivers drug-specific savings to patients, making PCSK9 therapy more affordable and more accessible.